Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis

Author: Morozzi G.   Fabbroni M.   Bellisai F.   Cucini S.   Simpatico A.   Galeazzi M.  

Publisher: Springer Publishing Company

ISSN: 0770-3198

Source: Clinical Rheumatology, Vol.26, Iss.8, 2007-08, pp. : 1335-1338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content